Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

United States Healthcare Advertising Market: By Product Type: Pharmaceuticals (Small Molecule Drugs) Advertising Market, Biopharmaceuticals Market, Others; Current Trends in Healthcare Advertising; Historical Market and Forecast (2018-2028); Market Dynamics; Market Challenges; Competitive Landscape; Industry Events and Developments

United States Healthcare Advertising Market Outlook

The United States healthcare advertising market size reached a value of almost USD 20.8 billion in the year 2020. The market is further expected to grow at a CAGR of 4.8% between 2021 and 2026 to reach a value of almost USD 26.5 billion by 2026.

 

United States Healthcare Advertising Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The United States healthcare advertising market is driven by the rising prescription drug advertisements. The industry for healthcare advertising in the United States has evolved substantially after the initiation of the first code of ethics, which happened in the late 1840s. This code involved the prohibition of any advertising associated with healthcare and pharmaceutical products. However, healthcare advertising is now used for the purpose of spreading awareness regarding several diseases, health issues, the availability of modern drugs, and procedures in the country. As opposed to advertising in other industries, healthcare advertising is controlled by regulations issued by the Federal Trade Commission, state consumer protection organisations, and other regulatory bodies.

 

Properties and Applications

Healthcare advertising is referred to as the advertisement of healthcare and pharmaceutical products to the general population, with the purpose of disseminating awareness regarding different ailments and their remedial procedures and treatment available in the market.

 

United States Healthcare Advertising Market By Product Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry is segmented on the basis product type of:

  • Pharmaceuticals (Small Molecule Drugs) Advertising Market
  • Biopharmaceuticals Market
  • Vaccines Market
  • Over-the-Counter Drugs Market
  • Others

Among all of these, advertisements in the pharmaceuticals (small molecule drugs) market have shown an exponential increase in the last few years.

 

United States Healthcare Advertising Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The United States healthcare advertising market is driven by the growth opportunities offered to several pharmaceutical marketers by online direct-to-consumer drug advertising. On account of this, they have started shifting their promotional spending on digital promotions such as product web sites, online display advertising, and social media campaigns. In addition to this, Google has permitted the advertisement of prescription drugs, addiction services, HIV home tests, and clinical trial recruitment across the country, further aiding the growth of the industry.

The industry is further invigorated by the advertisement of the medications, which is done after obtaining the certification permitting the usage of relevant keywords. Moreover, many pharmaceutical companies have begun advertising through different channels like multiple synchronised communication channels to boost their consumer reach. Apart from this, the technological advancement over the years has empowered consumers to find relevant information concerning various health-related conditions and the various available treatments. On account of this, the industry is witnessing an increase and is expected to expand over the forecast period.

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the healthcare advertising market in the United States, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Johnson & Johnson
  • Pfizer Inc
  • Merck & Co., Inc
  • GlaxoSmithKline plc.
  • Eli Lilly and Company
  • Novartis AG
  • Sanofi-Aventis U.S. LLC
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Bristol- Myers Squibb Company
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type
Breakup by Product Type Pharmaceuticals (Small Molecule Drugs) Advertising Market, Biopharmaceuticals Market, Vaccines Market, Over-the-Counter Drugs Market, Others
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc.,
Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC,
AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol- Myers Squibb Company, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    United States Healthcare Advertising Market Snapshot
7    Industry Opportunities and Challenges

    7.1    What Drives the Healthcare Advertising Market in the US?
        7.1.1    Digitalization and other Technological Advancements
        7.1.2    Increasing Presence of Generic and Me-too Drugs
        7.1.3    Government Regulations Supporting DTC Advertising
        7.1.4    Launch of New Drugs
        7.1.5    Increased Consumer Reach through Mobile Advertising
        7.1.6    Other Key Drivers
    7.2    Market Challenges
        7.2.1    Trust Gap between Consumers and Advertisers
        7.2.2    Strict Rules and Regulations by FDA
        7.2.3    Unethical Practices
        7.2.4    Macroeconomic Scenario
        7.2.5    Other Challenges
8    United States Healthcare Advertising Market Analysis
    8.1    Key Industry Highlights
    8.2    United States Healthcare Advertising Historical Market (2018-2022) 
    8.3    United States Healthcare Advertising Market Forecast (2023-2028)
    8.4    United States Healthcare Advertising Market by Product Type
        8.4.1    Pharmaceuticals (Small Molecule Drugs) Advertising Market
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
            8.4.1.4    Breakup by Advertising Channel
            8.4.1.5    Advertising Spend by Key Players
        8.4.2    Biopharmaceuticals Market
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
            8.4.2.4    Breakup by Advertising Channel
            8.4.2.5    Advertising Spend by Key Players
        8.4.3    Vaccines Market
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
            8.4.3.4    Breakup by Advertising Channel
            8.4.3.5    Advertising Spend by Key Players
        8.4.4    Over-the-Counter Drugs Market
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
            8.4.4.4    Breakup by Advertising Channel
            8.4.4.5    Advertising Spend by Key Players
        8.4.5    Others
9    Current Trends in Healthcare Advertising
    9.1    Focus on Content
    9.2    Rise of Multichannel Marketing
    9.3    Targeting Consumers with Local Advertising
    9.4    Reliance on Social Media
    9.5    Surging Mobile Marketing
    9.6    Consumers Becoming Researchers
    9.7    Information Dispensed through Videos
    9.8    Increasing Importance of Online Reviews 
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
            10.2.1    Supplier’s Power
            10.2.2    Buyers Power
            10.2.3    Threat of New Entrants
            10.2.4    Degree of Rivalry
            10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Market Challenges
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players’ Sales and Advertising Spend
    13.3    Company Profiles
        13.3.1    Johnson & Johnson Services, Inc 
            13.3.1.1    Company Overview
            13.3.1.2    Financial Summary
            13.3.1.3    Advertising Spend by Channel
            13.3.1.4    Global Sales and Advertising Spend
            13.3.1.5    Certifications
        13.3.2    Pfizer Inc
            13.3.2.1    Company Overview
            13.3.2.2    Financial Summary
            13.3.2.3    Advertising Spend by Channel
            13.3.2.4    Global Sales and Advertising Spend
            13.3.2.5    Certifications
        13.3.3    Merck & Co., Inc
            13.3.3.1    Company Overview
            13.3.3.2    Financial Summary
            13.3.3.3    Advertising Spend by Channel
            13.3.3.4    Global Sales and Advertising Spend
            13.3.3.5    Certifications
        13.3.4    GlaxoSmithKline plc.
            13.3.4.1    Company Overview
            13.3.4.2    Financial Summary
            13.3.4.3    Advertising Spend by Channel
            13.3.4.4    Global Sales and Advertising Spend
            13.3.4.5    Certifications
        13.3.5    Eli Lilly and Company
            13.3.5.1    Company Overview
            13.3.5.2    Financial Summary
            13.3.5.3    Advertising Spend by Channel
            13.3.5.4    Global Sales and Advertising Spend
            13.3.5.5    Certifications
        13.3.6    Novartis AG
            13.3.6.1    Company Overview
            13.3.6.2    Financial Summary
            13.3.6.3    Advertising Spend by Channel
            13.3.6.4    Global Sales and Advertising Spend
            13.3.6.5    Certifications
        13.3.7    Sanofi-Aventis U.S. LLC
            13.3.7.1    Company Overview
            13.3.7.2    Financial Summary
            13.3.7.3    Advertising Spend by Channel
            13.3.7.4    Global Sales and Advertising Spend
            13.3.7.5    Certifications
        13.3.8    AstraZeneca
            13.3.8.1    Company Overview
            13.3.8.2    Financial Summary
            13.3.8.3    Advertising Spend by Channel
            13.3.8.4    Global Sales and Advertising Spend
            13.3.8.5    Certifications
        13.3.9    F. Hoffmann-La Roche Ltd
            13.3.9.1    Company Overview
            13.3.9.2    Financial Summary
            13.3.9.3    Advertising Spend by Channel
            13.3.9.4    Global Sales and Advertising Spend
            13.3.9.5    Certifications
        13.3.10    Bayer AG
            13.3.10.1    Company Overview
            13.3.10.2    Financial Summary
            13.3.10.3    Advertising Spend by Channel
            13.3.10.4    Global Sales and Advertising Spend
            13.3.10.5    Certifications
        13.3.11    Bristol-Myers Squibb Company
            13.3.11.1    Company Overview
            13.3.11.2    Financial Summary
            13.3.11.3    Advertising Spend by Channel
            13.3.11.4    Global Sales and Advertising Spend
            13.3.11.5    Certifications
        13.3.12    Others
14    Industry Events and Developments

 

List of Key Figures and Tables

1.    United States Healthcare Advertising Market: Key Industry Highlights, 2018 and 2028
2.    United States Healthcare Advertising Historical Market: Breakup by Product Type (USD Billion), 2018-2022
3.    United States Healthcare Advertising Market Forecast: Breakup by Product Type (USD Billion), 2023-2028
4.    United States Generic Drug Market Structure

Key Questions Answered in the Report

In 2020, the healthcare advertising market in the United States attained a value of nearly USD 20.8 billion.

The market is projected to grow at a CAGR of 4.8% between 2021 and 2026.

The market is estimated to witness a moderate growth in the forecast period of 2023-2028 to reach about USD 26.5 billion by 2026.

The major drivers of the industry, such as rising advertisements for prescription drugs, growth opportunities offered to several pharmaceutical marketers, and the rising number of health-conscious consumers in the country, are expected to aid the market growth.

The key trends guiding the growth of the industry include the rise of multichannel marketing and targeting consumers with local advertising.

Pharmaceuticals (small molecule drugs) advertising market is the dominant product type in the industry.

The major players in the industry are Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, and Bristol- Myers Squibb Company, among others.

Analyst Review

The United States healthcare advertising market attained a value of USD 20.8 billion in 2020, driven by the rising advertisements of prescription drugs. Aided by the rise of multichannel marketing, the industry is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 4.8%. The healthcare advertising market in the United States is projected to reach USD 26.5 billion by 2026.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the pharmaceuticals (small molecule drugs) advertising market accounts for the leading share in the industry. The key players in the above industry include Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol- Myers Squibb Company, and others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER